In a recent study in NEPC [118] using cancer cell lines, patient-derived organoid and large patient datasets, the expression of SWI/SNF complex was found to be altered in NEPC and higher expression of SMARCA4 (BRG1), an SWI/SNF subunit, correlated with disease aggressiveness. Here, SMARCA1 is linked to cancer.